Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03863431
Other study ID # R18-P222
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 22, 2019
Est. completion date June 2021

Study information

Verified date February 2021
Source Loughborough University
Contact Carl Hulston, PhD
Phone +44 (0)1509 226449
Email c.j.hulston@lboro.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will investigate the effect of high-carbohydrate vs. high-fat overfeeding (130% of energy requirements) on whole body insulin sensitivity. Following habitual diet, participants will be randomly allocated to either a high-carbohydrate or a high-fat diet intervention for 14-days. On days 0, 7 and 14 participants will undergo anthropometric and metabolic testing (primarily an oral glucose tolerance test [OGTT]).


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date June 2021
Est. primary completion date June 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - 18-40 years - BMI = 18.5-29.9 kg/m2 - Male or female - Physically active (> 3 x 30 min moderate exercise per week) - Non-smoker (including the use of vaporisers and e-cigarettes) - Healthy (determined by the School's standard health questionnaire) - No cardiometabolic or inflammatory illness Exclusion Criteria: - Outside of age-range - Outside BMI range - Inactive (< 3 x 30 min moderate exercise per week) - Smoker - Taking medication - History of cardiometabolic or inflammatory illness - Vegetarian/ vegan (as the high-fat diet is based on animal fats) - Other dietary restrictions which prevent consumption of the experimental diet - Consumption of probiotics within last 3 months (these influence the gut microbiota) - Participation in another clinical trial - Those with known or suspected food intolerances, allergies or hypersensitivity - Women who are known to be pregnant or who are intending to become pregnant over the course of the study

Study Design


Intervention

Other:
High-fat diet
Participants will consume a high fat diet for 14 days with approximately 65% of energy from fat. The diet will also provide an energy excess, at 130% of energy requirements. Participants will be provided with all of their meals and snacks throughout the study.
High-carbohydrate diet
Participants will consume a high fat diet for 14 days with approximately 70% of energy from carbohydrate. The diet will also provide an energy excess, at 130% of energy requirements. Participants will be provided with all of their meals and snacks throughout the study.

Locations

Country Name City State
United Kingdom School of Sport, Exercise and Health Sciences Loughborough Leicestershire

Sponsors (1)

Lead Sponsor Collaborator
Loughborough University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Whole-body insulin sensitivity index Assessed by oral glucose tolerance test The change between pre-, during and post- dietary interventions: Assessed on days 0, 7 and 14
Secondary Body Mass Index Calculated from height and weight Day 0, Day 7, Day 14
Secondary Fasting plasma glucose concentration Measured in fasting plasma sample by spectrophotometric assay Day 0, Day 7, Day 14
Secondary Fasting serum insulin concentration Measured in fasting serum sample by ELISA Day 0, Day 7, Day 14
Secondary Fasting plasma lipid profile (for example total and HDL cholesterol and TAG concentrations; all measured in mmol/L) Measured in fasting plasma sample by spectrophotometric assay Day 0, Day 7, Day 14
Secondary Indirect calorimetry Measured from expired gas samples Day 0, Day 7, Day 14
Secondary Subjective appetite ratings Measured from visual analogue scale appetite questionnaires Day 0, Day 7, Day 14
See also
  Status Clinical Trial Phase
Completed NCT05219994 - Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum N/A
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Completed NCT02284893 - Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone Phase 3
Completed NCT04274660 - Evaluation of Diabetes and WELLbeing Programme N/A
Active, not recruiting NCT05887817 - Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Phase 4
Active, not recruiting NCT05566847 - Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Completed NCT04965506 - A Study of IBI362 in Chinese Patients With Type 2 Diabetes Phase 2
Recruiting NCT06115265 - Ketogenic Diet and Diabetes Demonstration Project N/A
Active, not recruiting NCT03982381 - SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes Phase 4
Completed NCT04971317 - The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages N/A
Completed NCT04496154 - Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood N/A
Completed NCT04023539 - Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05530356 - Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Completed NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Completed NCT04097600 - A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets Phase 1
Completed NCT05378282 - Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
Active, not recruiting NCT06010004 - A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Phase 3
Completed NCT03653091 - Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes N/A